» Articles » PMID: 34014785

Comparative Evaluation of a Dual-target Real-time RT-PCR Assay for COVID-19 Diagnosis and Assessment of Performance in Pooled Saliva and Nasopharyngeal Swab Samples

Overview
Specialty Molecular Biology
Date 2021 May 20
PMID 34014785
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Sensitive molecular diagnostic assays are essential for COVID-19 diagnosis. We evaluated the Hecin Scientific SARS-CoV-2 nucleic acid test kit, a dual-target real-time RT-PCR assay targeting the SARS-CoV-2 N and ORF1ab genes.

Methods: The Hecin test kit's diagnostic performance in detecting SARS-CoV-2 RNA was compared to the LightMix Modular SARS and Wuhan CoV E-gene kit (TIB Molbiol) and an in-house single-tube nested real-time RT-PCR using 296 clinical specimens, 11 proficiency testing samples, and 30 low-positive deep throat saliva and nasopharyngeal swab (NPS) samples pooled into negative samples in ratios of 1:5, 1:10, and 1:30.

Results: The limit-of-detection of the Hecin test kit was around 500 dC/mL for the N and ORF1ab targets. Sensitivity and specificity of the Hecin test kit were 98.1% (95% CI: 93.4-99.8%) and 100% (98.1-100%), respectively, when measured against the reference method. The Hecin test kit showed fair sensitivity (80%) in low-positive NPS samples pooled in ratios of 1:5 and 1:10. Its performance in pooled samples could be dramatically improved by adjusting the assay Ct cutoff.

Conclusion: The Hecin test kit enables sensitive and specific detection of SARS-CoV-2 in clinical samples and pooled samples.

Citing Articles

The Diagnostic Performance of Various Clinical Specimens for the Detection of COVID-19: A Meta-Analysis of RT-PCR Studies.

Al-Shaibari K, Mousa H, Alqumber M, Alqfail K, Mohammed A, Bzeizi K Diagnostics (Basel). 2023; 13(19).

PMID: 37835801 PMC: 10572802. DOI: 10.3390/diagnostics13193057.


Performance evaluation of Biofire Film Array Respiratory Panel 2.1 for SARS-CoV-2 detection in a pediatric hospital setting.

Ramirez M, Zarate M, Rodriguez L, Aquino V PLoS One. 2023; 18(10):e0292314.

PMID: 37797063 PMC: 10553804. DOI: 10.1371/journal.pone.0292314.


Development and Validation of a Novel COVID-19 nsp8 One-Tube RT-LAMP-CRISPR Assay for SARS-CoV-2 Diagnosis.

Yip C, Sridhar S, Chan W, Ip J, Chu A, Leung K Microbiol Spectr. 2022; 10(6):e0196222.

PMID: 36445095 PMC: 9769742. DOI: 10.1128/spectrum.01962-22.


An improvement of current hypercube pooling PCR tests for SARS-CoV-2 detection.

Wu T, Liao Y, Fuh C, Weng P, Wang J, Chen C Front Public Health. 2022; 10:994712.

PMID: 36339215 PMC: 9627488. DOI: 10.3389/fpubh.2022.994712.

References
1.
Igloi Z, Leven M, Abdel-Karem Abou-Nouar Z, Weller B, Matheeussen V, Coppens J . Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2. J Clin Virol. 2020; 129:104510. PMC: 7833356. DOI: 10.1016/j.jcv.2020.104510. View

2.
Yip C, Sridhar S, Cheng A, Leung K, Choi G, Chen J . Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection. J Clin Virol. 2020; 129:104476. PMC: 7255195. DOI: 10.1016/j.jcv.2020.104476. View

3.
Yip C, Ho C, Chan J, To K, Chan H, Wong S . Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens. Int J Mol Sci. 2020; 21(7). PMC: 7177594. DOI: 10.3390/ijms21072574. View

4.
Lee J, Kim S, Sung H, Lee S, Lee H, Roh K . Challenges and issues of SARS-CoV-2 pool testing. Lancet Infect Dis. 2020; 20(11):1232-1233. PMC: 7833783. DOI: 10.1016/S1473-3099(20)30516-8. View

5.
Yip C, Sridhar S, Leung K, Ng A, Chan K, Chan J . Development and Evaluation of Novel and Highly Sensitive Single-Tube Nested Real-Time RT-PCR Assays for SARS-CoV-2 Detection. Int J Mol Sci. 2020; 21(16). PMC: 7461039. DOI: 10.3390/ijms21165674. View